The non-HDL-C/HDL-C ratio provides cardiovascular risk stratification similar to the ApoB/ApoA1 ratio in diabetics: Comparison with reference lipid markers

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 1, Issue 1, 2007, Pages 23-28

  Hermans, Michel P ^a   Ahn, Sylvie A ^a   Rousseau, Michel F ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cost benefit analysis; Diabetes mellitus; Lipid cardiovascular risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DISCRIMINANT ANALYSIS; DISEASE SEVERITY; DYSLIPIDEMIA; ENZYMATIC ASSAY; FEMALE; HEALTH CARE COST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MALE; METABOLIC SYNDROME X; NEPHELOMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 34247869812     PISSN: 18714021     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dsx.2006.11.003     Document Type: Article

References (13)

1. Denke M.A. Weighing in before the fight. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol versus Apolipoprotein B as the best predictor for coronary heart disease and the best measure of therapy. Circulation 112 (2005) 3368-3370
2. Pischon T., Girman C.J., Sacks F.M., Rifai N., Stampfer M.J., and Rimm E.B. Non-high-density lipoprotein cholesterol and Apolipoprotein B in the prediction of coronary heart disease in men. Circulation 112 (2005) 3375-3383
3. Sniderman A.D. Apolipoprotein B versus non-high-density lipoprotein cholesterol. And the winner is .... Circulation 112 (2005) 3366-3367
4. Walldius G., Jungner I., Holme I., Aastveit A.H., Kolar W., and Steiner E. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 358 (2001) 2026-2033
5. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. On behalf of the INTERHEART investigators, effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
6. Lu W., Resnick H.E., Jablonski K.A., Jones K.L., Jain A.K., Howard W.J., et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diab Care 26 (2003) 16-23
7. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
8. Holman R.R., Coleman R.L., Shine S., and Stevens R.J. Non-HDL cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes. Diab Care 28 (2005) 1796-1797
9. Levy J., Morris R., Hammersley M., and Turner R. Discrimination, adjusted correlation, and equivalence of imprecise tests: application to glucose tolerance. Am J Physiol 276 (1999) E365-E375
10. Hermans M.P., Levy J.C., Morris R.J., and Turner R.C. Comparison of insulin sensitivity tests across a range of glucose tolerance form normal to diabetes. Diabetologia 42 (1999) 678-687
11. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
12. Gotto A., and Pownall H. Plasma lipoproteins: structure, nomenclature and occurrence. Manual of lipid disorders. Reducing the risk for coronary heart disease. 2nd ed. (1999), Williams and Wilkins, Baltimore pp. 2-10
13. Gotto A., and Pownall H. Remodeling of plasma lipoproteins in the plasma compartment. Manual of lipid disorders. Reducing the risk for coronary heart disease. 2nd ed. (1999), Williams and Wilkins, Baltimore pp. 21-39